Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Styrenix Performance Materials Ltd. (STYRENIX.NS)
Vadodara, IN
Styrenix Performance Materials Limited is an Indian company dedicated to the production, marketing, and distribution of engineering thermoplastics. Its extensive product range includes Absolac, a plastic resin widely used in automotive interior and exterior components, home appliances, and electronic device enclosures. Absolan serves various sectors, finding application in industrial goods, cosmetic packaging, stationery, electrical products, and household items, including cosmetic jars. The company also provides General Purpose Polystyrene (GPPS), a transparent polymer crucial for TV light diffuser plates, XPS insulation boards, refrigerator drawers, medical labware, disposable packaging, CD jewel boxes, and clothes hangers. High Impact Polystyrene Resin (HIPS) is supplied for electronic goods housing, refrigerator internal and door linings, injection molded articles, beverage cups, dairy product containers, sheets, disposables, yogurt bottles, and toys. Additionally, Styrenix offers Styroloy, a blended material for automotive (both exterior and interior), household, and electronics applications, along with Asalac, a polymer specifically for vehicle exterior and interior uses. Incorporated in 1973 and headquartered in Vadodara, India, the company was formerly known as INEOS Styrolution India Limited, rebranding to its current name in January 2023.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.11% | +4.06% | -1.85% | +19.07% | +9.19% | +15.35% | -21.11% | +163.91% | +70.47% | +283.62% | +3,469.64% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%+15.3% ★ Q1'26: -12.1% (vs Q1'25)
-
EPS growth Chemicals: +11.7%-22.2% Q1'26: +30.9% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+2.8% ★ Q1'26: -17.0% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+7.1% Q1'26: +11.8% (vs Q1'25)
-
ROIC Chemicals: +3.4%+11.4% ★ Q1'26: +17.7% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+0.0% Q1'26: 0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×1.54× Q1'26: 1.07× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
Mar 2031 1 Rev. Ana. 1 EPS Ana. |
Mar 2032 1 Rev. Ana. 1 EPS Ana. |
Mar 2033 1 Rev. Ana. 1 EPS Ana. |
Mar 2034 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
35.29B
est.
|
29.82B
est: 28.40B (+5.0%)
|
35.29B
35.29B – 35.29B
+24.2% YoY
|
40.85B
40.85B – 40.85B
+15.8% YoY
|
48.98B
48.98B – 48.98B
+19.9% YoY
|
21.65B
21.65B – 21.65B
-55.8% YoY
|
24.25B
24.25B – 24.25B
+12.0% YoY
|
1.60B
1.60B – 1.60B
-93.4% YoY
|
1.90B
1.90B – 1.90B
+18.8% YoY
|
28.40B
28.40B – 28.40B
+1,394.7% YoY
|
31.39B
31.39B – 31.39B
+10.5% YoY
|
| EBITDA |
4.29B
est.
|
3.63B
est: 3.45B (+5.0%)
|
4.29B
4.29B – 4.29B
+24.2% YoY
|
4.97B
4.97B – 4.97B
+15.8% YoY
|
5.96B
5.96B – 5.96B
+19.9% YoY
|
2.63B
2.63B – 2.63B
-55.8% YoY
|
2.95B
2.95B – 2.95B
+12.0% YoY
|
194.56M
194.56M – 194.56M
-93.4% YoY
|
231.04M
231.04M – 231.04M
+18.7% YoY
|
3.45B
3.45B – 3.45B
+1,394.7% YoY
|
3.82B
3.82B – 3.82B
+10.5% YoY
|
| EBIT |
3.66B
est.
|
3.09B
est: 2.95B (+5.0%)
|
3.66B
3.66B – 3.66B
+24.2% YoY
|
4.24B
4.24B – 4.24B
+15.8% YoY
|
5.08B
5.08B – 5.08B
+19.9% YoY
|
2.25B
2.25B – 2.25B
-55.8% YoY
|
2.52B
2.52B – 2.52B
+12.0% YoY
|
166.00M
166.00M – 166.00M
-93.4% YoY
|
197.12M
197.12M – 197.12M
+18.8% YoY
|
2.95B
2.95B – 2.95B
+1,394.7% YoY
|
3.26B
3.26B – 3.26B
+10.5% YoY
|
| Net Income |
1.56B
est.
|
27.49M
est: 2.46B (-98.9%)
|
1.56B
1.56B – 1.56B
-36.5% YoY
|
1.87B
1.87B – 1.87B
+19.6% YoY
|
2.37B
2.37B – 2.37B
+27.0% YoY
|
752.22M
752.22M – 752.22M
-68.2% YoY
|
878.80M
878.80M – 878.80M
+16.8% YoY
|
1.87B
1.87B – 1.87B
+112.4% YoY
|
2.15B
2.15B – 2.15B
+15.1% YoY
|
2.46B
2.46B – 2.46B
+14.3% YoY
|
2.80B
2.80B – 2.80B
+13.8% YoY
|
| SGA |
986.82M
est.
|
834.10M
est: 794.27M (+5.0%)
|
986.82M
986.82M – 986.82M
+24.2% YoY
|
1.14B
1.14B – 1.14B
+15.8% YoY
|
1.37B
1.37B – 1.37B
+19.9% YoY
|
605.56M
605.56M – 605.56M
-55.8% YoY
|
678.23M
678.23M – 678.23M
+12.0% YoY
|
44.75M
44.75M – 44.75M
-93.4% YoY
|
53.14M
53.14M – 53.14M
+18.8% YoY
|
794.27M
794.27M – 794.27M
+1,394.7% YoY
|
877.89M
877.89M – 877.89M
+10.5% YoY
|
| EPS |
88.70
est.
|
133.72
est: 139.70 (-4.3%)
|
88.70
88.70 – 88.70
-36.5% YoY
|
106.10
106.10 – 106.10
+19.6% YoY
|
134.70
134.70 – 134.70
+27.0% YoY
|
42.77
42.77 – 42.77
-68.2% YoY
|
49.97
49.97 – 49.97
+16.8% YoY
|
106.13
106.13 – 106.13
+112.4% YoY
|
122.19
122.19 – 122.19
+15.1% YoY
|
139.70
139.70 – 139.70
+14.3% YoY
|
159.00
159.00 – 159.00
+13.8% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-26 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-25 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-19 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-18 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-15 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-14 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-13 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.02% | 143.6K | 0.65% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Rahul Rakesh Agrawal | MD & Executive Director | 29M | male |
| Rakesh Shivbhagwan Agrawal | Executive Non-Independent Chairman | 29M | male |
| Bhupesh Porwal | Chief Financial Officer | 12M | male |
| Ravishankar Balakoteswararao Kompalli | Executive Whole-Time Director | 11M | male |
| Munjal Parekh | Head of Business Partnering India & SM Asia - Finance | — | male |
| L. Sundar | Executive Vice President of Marketing | — | male |
| Chintan Doshi | Manager Legal, Company Secretary & Compliance Officer | — | male |
| Vishal Rakesh Agrawal | Joint MD & Executive Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for STYRENIX.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
